Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Ouest-France

July 3, 2020

Coronavirus. Un premier patient testé à Nice avec un traitement expérimental à base d’ABX464

Drug Discovery World

July 3, 2020

Abivax treats first patient in COVID-19 clinical trial in France

4 investors

July 2, 2020

Abivax: Erster COVID-19-Patient in klinischer Studie behandelt

Der Aktionär

July 2, 2020

AKTIONÄR-Hot-Stock Abivax: Fortschritte bei Corona-Therapie – die Details

20minutes

July 2, 2020

Coronavirus : Un nouveau traitement testé au CHU de Nice, plus de mille patients vont participer à un essai

  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn